Safety and Tolerability of Lenvatinib in Advanced Non-medullary Thyroid Carcinoma: A Multicenter Retrospective Cohort Study From Southwestern Colombia
Cureus · 21.11.2026
DOI: 10.7759/cureus.120046 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cureus, erschienen am 21.11.2026. Verfasst von Andrés Felipe García Ramos und 10 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ramos, A. F. G., Ospina, J. H. Q., Berrocal, C., Paz, E. J. S., Gómez, N. B., Bonilla, M. A. U., Segura, B. D. Z., Gil, M. R., Gonzalez, A. M. P., Lomba, A. A., & Román-González, A. (2026). Safety and Tolerability of Lenvatinib in Advanced Non-medullary Thyroid Carcinoma: A Multicenter Retrospective Cohort Study From Southwestern Colombia. Cureus. https://doi.org/10.7759/cureus.120046
Vancouver
Ramos AFG, Ospina JHQ, Berrocal C, Paz EJS, Gómez NB, Bonilla MAU, et al. Safety and Tolerability of Lenvatinib in Advanced Non-medullary Thyroid Carcinoma: A Multicenter Retrospective Cohort Study From Southwestern Colombia. Cureus. 2026. doi:10.7759/cureus.120046
BibTeX
@article{Ramos2026,
author = {Ramos, Andrés Felipe García and Ospina, Jhon Herney Quintana and Berrocal, Carlos and Paz, Eduardo José Serna and Gómez, Nathalia Buitrago and Bonilla, María Alejandra Urbano and Segura, Bryan David Zamora and Gil, Marcela Rojas and Gonzalez, Andrea Marcela Pantoja and Lomba, Alin Abreu and Román-González, Alejandro},
title = {Safety and Tolerability of Lenvatinib in Advanced Non-medullary Thyroid Carcinoma: A Multicenter Retrospective Cohort Study From Southwestern Colombia},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.120046}
}
EUVIMED